U.N. facility allocates 3 mil. doses of China's vaccine to North Korea

A U.N.-backed facility has newly allocated 3 million doses of coronavirus vaccine produced by China's major pharmaceutical company Sinovac Biotech Ltd. to North Korea, according to U.S. media.But it is uncertain whether North Korea will accept them, Radio Free Asia on Wednesday quoted an official of the World Health Organization as saying, with all eyes on when the nation will obtain vaccines for its people through the COVAX platform.North Korea was expected to receive around 2 million doses of vaccine produced by Britain's AstraZeneca Plc earlier this year, but the plan has been postponed …READ FULL ARTICLE